Biolife Solutions (BLFS) Interest & Investment Income (2010 - 2026)
Biolife Solutions (BLFS) reported Interest & Investment Income of $1.0 million for Q1 2026, up 52.42% year-over-year from $683000.0 in Q1 2025, and up 24.97% quarter-over-quarter from $833000.0 in Q4 2025.
Biolife Solutions (BLFS) Interest & Investment Income (2010 - 2026) Analysis & Trends
Biolife Solutions (BLFS) has 10 years of Interest & Investment Income data on file, last reported at $1.0 million in Q1 2026.
- Interest & Investment Income for Q1 2026 came in at $1.0 million, up 52.42% year-over-year; the trailing twelve-month figure through Mar 2026 was $3.1 million (up 5278.95% YoY), and the FY2025 annual result was $2.7 million, up 453.26% from the prior year.
- Interest & Investment Income climbed to $1.0 million in Q1 2026 per BLFS's latest filing, from $833000.0 in the prior quarter.
- Over five years, Interest & Investment Income peaked at $1.0 million in Q1 2026 and troughed at -$449000.0 in Q3 2023.
- A 5-year average of $76588.2 and a median of -$71000.0 in 2024 frame the typical range for Interest & Investment Income.
- The sharpest annual moves came in 2023 and 2025: Interest & Investment Income plunged 2893.33% in 2023, then surged 1273.24% in 2025.
- A 5-year view of Interest & Investment Income shows it stood at -$34000.0 in 2022, then tumbled by 458.82% to -$190000.0 in 2023, then surged by 62.63% to -$71000.0 in 2024, then surged by 1273.24% to $833000.0 in 2025, then rose by 24.97% to $1.0 million in 2026.
- Business Quant data shows BLFS's Interest & Investment Income at $1.0 million in Q1 2026, $833000.0 in Q4 2025, and $508000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Int & Inv Inc (Qtr) |
|---|---|---|---|---|---|
| 1 | Intuitive Surgical | 148.09 Bn | 143.69 Bn | 1.83 Bn | - |
| 2 | Becton Dickinson | 41.00 Bn | 39.99 Bn | 2.15 Bn | 9.00 Mn |
| 3 | Medline | 30.38 Bn | 36.22 Bn | 1.84 Bn | -136.00 Mn |
| 4 | Resmed | 28.22 Bn | 26.56 Bn | 890.98 Mn | 12.29 Mn |
| 5 | West Pharmaceutical Services | 23.72 Bn | 23.19 Bn | 296.40 Mn | 5.10 Mn |
| 6 | Solventum | 13.33 Bn | 13.33 Bn | 1.10 Bn | -62.00 Mn |
| 7 | Cooper Companies | 13.12 Bn | 12.99 Bn | 735.40 Mn | - |
| 8 | Align Technology | 12.86 Bn | 11.80 Bn | 736.59 Mn | 3.91 Mn |
| 9 | Baxter International | 10.51 Bn | 8.47 Bn | 891.00 Mn | -66.00 Mn |
| 10 | Biolife Solutions | 1.27 Bn | 1.19 Bn | 17.50 Mn | 1.04 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 1.04 Mn |
| Dec 31, 2025 | 833,000.00 |
| Sep 30, 2025 | 508,000.00 |
| Jun 30, 2025 | 684,000.00 |
| Mar 31, 2025 | 683,000.00 |
| Dec 31, 2024 | -71,000.00 |
| Sep 30, 2024 | -230,000.00 |
| Jun 30, 2024 | -325,000.00 |
| Mar 31, 2024 | -140,000.00 |
| Dec 31, 2023 | -190,000.00 |
| Sep 30, 2023 | -449,000.00 |
| Jun 30, 2023 | -387,000.00 |
| Mar 31, 2023 | -411,000.00 |
| Dec 31, 2022 | -34,000.00 |
| Sep 30, 2022 | -15,000.00 |
| Jun 30, 2022 | -32,000.00 |
| Mar 31, 2022 | -163,000.00 |
| Dec 31, 2021 | -154,000.00 |
| Sep 30, 2021 | -194,000.00 |
| Jun 30, 2021 | -121,000.00 |